OR WAIT 15 SECS
Jennifer Grebow is editor-in-chief of Nutritional Outlook.
Sirio specializes in delivery forms such as softgels, capsules, tablets, powders, gummies, and liquids.
Contract manufacturer Sirio Pharma Company, Ltd., (Shantou, China) has acquired European softgel manufacturer Ayanda GmbH. Sirio specializes in delivery forms such as softgels, capsules, tablets, powders, gummies, and liquids.
“Ayanda’s good reputation and production capacity in Europe will help Sirio to establish a global development and production service system,” said Sirio in a press release. “At the same time, Ayanda will also benefit from the multi-dosage-form production capacity of Sirio, creating more value for customers in the European market. Sirio and Ayanda will work together to integrate our collective production, service, and products. Together we complement each other’s advantages, and create much better values for customers.”
Sirio says it is approved via the following: TGA-GMP, NPA/UL GMP, BRC, UL’s Management System, 21 CFR Part 111, ISO 9001:2015 certification.
Nutritional Outlook magazine